- Research works
- 2 fractional, all time
- Citations
- 21 8.7 per fractional work
- Top-10% rate
- 36.7% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: CytaCoat (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does CytaCoat (Sweden) publish most on?
By volume in 2022–2025: Viral Infectious Diseases and Gene Expression in Insects, Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and RNA and protein synthesis mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 3 Protein purification and stability Molecular Biology 0 works
- 4 RNA and protein synthesis mechanisms Molecular Biology 0 works
- 5 Enterobacteriaceae and Cronobacter Research Endocrinology 0 works
- 6 Microbial Metabolic Engineering and Bioproduction Molecular Biology 0 works
- 7 Bacterial Genetics and Biotechnology Genetics 0 works
- 8 Urinary Tract Infections Management Epidemiology 0 works
- 9 Reproductive tract infections research Microbiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CytaCoat (Sweden)'s research output changed?
Other research institutions in Solna
- Bristol-Myers Squibb (Sweden)
- Abbott (Sweden)
- Public Health Agency of Sweden
- Stockholm International Peace Research Institute
- Swedish Space Corporation
- Radium Hemmets Research Funds
- Johnson & Johnson (Sweden)
- Karolinska Development (Sweden)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.